Tyra Biosciences, Inc. (TYRA)
32.84
-0.96
(-2.84%)
USD |
NASDAQ |
May 07, 14:14
Tyra Biosciences Cash from Investing (Quarterly) : 34.38M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 56.58M |
| Entrada Therapeutics, Inc. | 29.12M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Ionis Pharmaceuticals, Inc. | 536.82M |
| Agios Pharmaceuticals, Inc. | 141.31M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.62M |
| Cash from Financing (Quarterly) | 4.683M |
| Free Cash Flow | -95.28M |
| Free Cash Flow Per Share (Quarterly) | -0.3958 |
| Free Cash Flow to Equity (Quarterly) | -23.57M |
| Free Cash Flow to Firm (Quarterly) | -23.68M |
| Free Cash Flow Yield | -4.87% |